I Heard These Medications Give You Cancer. Is That True? Risks of Malignancy with IBD Therapy

Keyphrases

• Risk of Malignancy 100%
• Thiopurines 100%
• Infliximab 50%
• Cancer Risk 50%
• Inflammatory Bowel Disease 50%
• Skin Cancer 50%
• Cancer Types 50%
• Adalimumab 50%
• Lymphoma Cancer 50%
• Initiating Treatment 50%
• Anti-TNF Agents 50%
• Mercaptopurine 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Inflammatory Bowel Disease 100%
• Mercaptopurine 100%
• Tumor Necrosis Factor 33%
• Skin Cancer 33%
• Azathioprine 33%
• Adalimumab 33%
• Infliximab 33%
• Tumor Necrosis Factor Inhibitor 33%